The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant - Guangdong Province, China, December 2022 to January 2023.

Chunsheng Cai, Yihong Li, Ting Hu, Rongwei Liang, Kaibin Wang, Congrui Guo, Yan Li, Meng Zhang, Min Kang
{"title":"The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant - Guangdong Province, China, December 2022 to January 2023.","authors":"Chunsheng Cai,&nbsp;Yihong Li,&nbsp;Ting Hu,&nbsp;Rongwei Liang,&nbsp;Kaibin Wang,&nbsp;Congrui Guo,&nbsp;Yan Li,&nbsp;Meng Zhang,&nbsp;Min Kang","doi":"10.46234/ccdcw2023.075","DOIUrl":null,"url":null,"abstract":"<p><strong>What is already known about this topic?: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by variants is being reported commonly and has caused waves of epidemic in many countries. Because of dynamic zero policy, the SARS-CoV-2 reinfection was less reported in China.</p><p><strong>What is added by this report?: </strong>SARS-CoV-2 reinfections were observed in Guangdong Province between December 2022 and January 2023. This study estimated that the reinfection incidence was 50.0% for the original strain primary infections, 35.2% for the Alpha or Delta variants, and 18.4% for the Omicron variant; The reinfection incidence within 3-6 months after primary infection by Omicron variant was 4.0%. Besides, 96.2% reinfection cases were symptomatic while only 7.7% sought medical attention.</p><p><strong>What are the implications for public health practice?: </strong>These findings suggest a reduced likelihood of an Omicron-driven epidemic resurgence in the short term but emphasize the importance of maintaining vigilant surveillance of emerging SARS-CoV-2 variants and conducting population-based antibody level surveys to inform response preparedness.</p>","PeriodicalId":9867,"journal":{"name":"China CDC Weekly","volume":"5 18","pages":"391-396"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/ed/ccdcw-5-18-391.PMC10184471.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"China CDC Weekly","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46234/ccdcw2023.075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

What is already known about this topic?: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by variants is being reported commonly and has caused waves of epidemic in many countries. Because of dynamic zero policy, the SARS-CoV-2 reinfection was less reported in China.

What is added by this report?: SARS-CoV-2 reinfections were observed in Guangdong Province between December 2022 and January 2023. This study estimated that the reinfection incidence was 50.0% for the original strain primary infections, 35.2% for the Alpha or Delta variants, and 18.4% for the Omicron variant; The reinfection incidence within 3-6 months after primary infection by Omicron variant was 4.0%. Besides, 96.2% reinfection cases were symptomatic while only 7.7% sought medical attention.

What are the implications for public health practice?: These findings suggest a reduced likelihood of an Omicron-driven epidemic resurgence in the short term but emphasize the importance of maintaining vigilant surveillance of emerging SARS-CoV-2 variants and conducting population-based antibody level surveys to inform response preparedness.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2022年12月至2023年1月中国广东省SARS-CoV-2基因组变体再感染的相关因素
关于这个话题我们已经知道了什么?严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)变异体再感染正在普遍报告,并在许多国家引起了流行浪潮。由于动态零政策,中国SARS-CoV-2再感染报告较少。这份报告增加了什么内容?2022年12月至2023年1月,广东省出现SARS-CoV-2再感染病例。该研究估计,原始菌株原发性感染的再感染发生率为50.0%,α或δ变异为35.2%,Omicron变异为18.4%;原发感染后3 ~ 6个月内再感染发生率为4.0%。此外,96.2%的再感染病例有症状,而就医的仅占7.7%。这对公共卫生实践有什么影响?这些研究结果表明,短期内由欧米克隆驱动的疫情再次爆发的可能性降低,但强调了对新出现的SARS-CoV-2变体保持警惕监测和开展基于人群的抗体水平调查的重要性,以便为应对准备提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Injury Mortality of Children and Adolescents Aged 0–19 Years — China, 2010–2021 The Burden of Hypertension-Related Chronic Kidney Disease — China, 2010–2019 The Impact of New Regulations on Prevention and Control of E-Cigarettes on Adolescents in Middle Schools — A City in China, 2022–2023 State of the Art of Lifecourse Cohort Establishment Evaluation of the Effectiveness of “5E” Comprehensive Injury Prevention Strategy for Fall Prevention Among the Rural Elderly — Six Pilot Villages, Yunnan Province and Chongqing Municipality, China, 2018–2023
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1